Is the price fair?
What GMED's price assumes
Globus Medical, Inc. trades at 19.4× earnings against 33.4× for the median Medical Devices name, cheaper than its own group.
19.4
Trailing P/E · Medical Devices median 33.4 · cheaper than the typical name in its group
- Price / sales
- 3.84
Price / sales · as of 2026-Q1
- Free cash flow yield
- 5.7%
Free cash flow yield · Medical Devices median 4.0%
- Growth the price implies
- +4.0%
Growth the price implies · The price pays for +4.0% free cash flow growth a year for a decade; the business has delivered +73% a year over the last three.
Details›
- Price / book2026-Q1
- 2.52
- Healthcare median P/E362 names
- 31.5
- Medical Devices median P/E39 names
- 33.4
- Free cash flow, trailing twelve months
- $610M
- Market capitalisation
- $10.8B
- 3-year revenue growth
- +43%
- 3-year free cash flow growth
- +73%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $142.49 |
| Its own P/E history, median | $167.93 |
| Its own P/E history, upper quartile | $217.12 |
| 52-week range | $55.10 – $96.82 |
| Today | $83.13 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.